SHARE THIS VIDEO —
FDA approves first medical treatment for Alzheimer’s in 18 years
NBC News Clone summarizes the latest on: Mmvo114445381880 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.
The drug aducanumab, developed by the company Biogen, attacks the amyloid protein that builds up in the brain of Alzheimer’s patients. The drug is going on the market even though the FDA says there are “uncertainties regarding clinical benefits” and is requiring Biogen to do another clinical trial.
Want more summaries like this? Follow NBC News Clone for expertly filtered news from trusted sources.
